HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dermatonics Kicking Open The UK’s Foot-Care Category

Executive Summary

HBW Insight speaks to Dermatonics director Greg Ansell about how his company is using naturals and female-friendly packaging to break open the UK's crowded OTC foot-care category. 

You may also be interested in...

South Africa Next As HRA Pharma Marches On With Global Expansion

HRA Pharma brings Compeed to South Africa, moving the company one step closer to achieving its goal of becoming a top-10 global consumer healthcare player. 

TheOTCLab Looks To Gain A Foothold In Europe's OTC Market With FungeX

Beginning with its home market, the Netherlands, and also France, consumer healthcare specialist TheOTCLab is looking to establish a pan-European presence in the region's foot-care market with its new FungeX range of nail fungus and athletes' foot products. 

Trimb Invests To Grow Nailner In The UK

Swedish manufacturer Trimb Healthcare speaks exclusively to HBW Insight about how it has grown its foot-care brand in the UK through investments in line extensions and seasonal marketing campaigns.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts